Although our study provided a relatively small cohort of ovarian cancer cases, the Notch gene biomarker combination was able to perfectly discriminate HGSOC cases from the benign gynecologic tumor cases, albeit the best single biomarker CTNNB1 was also able to sufficiently separate these cases by itself. This evidence concerns the gene CTNNB1 and ovarian carcinoma.